BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 19890967)

  • 21. Helicobacter pylori infection does not correlate with plasma ammonia concentration and hepatic encephalopathy in patients with cirrhosis.
    Huber M; Rössle M; Siegerstetter V; Ochs A; Haag K; Kist M; Blum HE
    Hepatogastroenterology; 2001; 48(38):541-4. PubMed ID: 11379349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Detection of subclinical and overt hepatic encephalopathy and treatment control after L-ornithine-L-aspartate medication by magnetic resonance spectroscopy ((1)H-MRS)].
    Hass HG; Nägele T; Seeger U; Hösl F; Gregor M; Kaiser S
    Z Gastroenterol; 2005 Apr; 43(4):373-8. PubMed ID: 15830303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of oxidative stress in the ammonia-induced mitochondrial permeability transition in cultured astrocytes.
    Rama Rao KV; Jayakumar AR; Norenberg MD
    Neurochem Int; 2005 Jul; 47(1-2):31-8. PubMed ID: 15908047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microglia activation in hepatic encephalopathy in rats and humans.
    Zemtsova I; Görg B; Keitel V; Bidmon HJ; Schrör K; Häussinger D
    Hepatology; 2011 Jul; 54(1):204-15. PubMed ID: 21452284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversal of diuretic-induced hepatic encephalopathy with infusion of albumin but not colloid.
    Jalan R; Kapoor D
    Clin Sci (Lond); 2004 May; 106(5):467-74. PubMed ID: 14678008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of acute hepatic encephalopathy and in vitro treatment with ammonia on glutamate oxidation in bulk-isolated astrocytes and mitochondria of the rat brain.
    Wysmyk-Cybula U; Faff-Michalak L; Albrecht J
    Acta Neurobiol Exp (Wars); 1991; 51(5-6):165-9. PubMed ID: 1687972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minimal hepatic encephalopathy: time to recognise and treat.
    Dhiman RK; Chawla YK
    Trop Gastroenterol; 2008; 29(1):6-12. PubMed ID: 18564660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathogenesis and diagnosis of hepatic encephalopathy.
    McPhail MJ; Bajaj JS; Thomas HC; Taylor-Robinson SD
    Expert Rev Gastroenterol Hepatol; 2010 Jun; 4(3):365-78. PubMed ID: 20528123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hepatic encephalopathies; hemodynamic and metabolic study of the influence of ammonia and levodopa].
    Baldy-Moulinier M; Bories P; Michel H; Passouant P
    Rev Neurol (Paris); 1977 Mar; 133(3):175-89. PubMed ID: 918461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Astrocyte swelling and protein tyrosine nitration in hepatic encephalopathy.
    Häussinger D; Schliess F
    Neurochem Int; 2005 Jul; 47(1-2):64-70. PubMed ID: 15908046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The importance of bacterial infections as precipating factors of chronic hepatic encephalopathy in cirrhosis.
    Strauss E; da Costa MF
    Hepatogastroenterology; 1998; 45(21):900-4. PubMed ID: 9684155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement of hepatic encephalopathy using a modified high-calorie high-protein diet.
    Gheorghe L; Iacob R; Vădan R; Iacob S; Gheorghe C
    Rom J Gastroenterol; 2005 Sep; 14(3):231-8. PubMed ID: 16200232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral glutamine challenge in cirrhotics pre- and post-liver transplantation: a psychometric and analyzed EEG study.
    Oppong KN; Al-Mardini H; Thick M; Record CO
    Hepatology; 1997 Oct; 26(4):870-6. PubMed ID: 9328307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regional differences in cerebral blood flow and cerebral ammonia metabolism in patients with cirrhosis.
    Ahl B; Weissenborn K; van den Hoff J; Fischer-Wasels D; Köstler H; Hecker H; Burchert W
    Hepatology; 2004 Jul; 40(1):73-9. PubMed ID: 15239088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complications of cirrhosis III. Hepatic encephalopathy.
    Butterworth RF
    J Hepatol; 2000; 32(1 Suppl):171-80. PubMed ID: 10728803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis.
    Sharma P; Sharma BC; Sarin SK
    Liver Int; 2009 Oct; 29(9):1365-71. PubMed ID: 19555401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetes mellitus is associated with hepatic encephalopathy in patients with HCV cirrhosis.
    Sigal SH; Stanca CM; Kontorinis N; Bodian C; Ryan E
    Am J Gastroenterol; 2006 Jul; 101(7):1490-6. PubMed ID: 16863551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebral abnormalities in patients with cirrhosis detected by proton magnetic resonance spectroscopy and magnetic resonance imaging.
    Geissler A; Lock G; Fründ R; Held P; Hollerbach S; Andus T; Schölmerich J; Feuerbach S; Holstege A
    Hepatology; 1997 Jan; 25(1):48-54. PubMed ID: 8985263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic inflammation and ammonia in hepatic encephalopathy.
    Tranah TH; Vijay GK; Ryan JM; Shawcross DL
    Metab Brain Dis; 2013 Mar; 28(1):1-5. PubMed ID: 23224356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxidative stress: a systemic factor implicated in the pathogenesis of hepatic encephalopathy.
    Bosoi CR; Rose CF
    Metab Brain Dis; 2013 Jun; 28(2):175-8. PubMed ID: 23124921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.